Academic Identity

Vidwan-ID : 111264

Edit Profile


  • Prof Rakesh Bhatnagar

  • Vice Chancellor
  • Amity University, Noida
Publications 1971 - 2021

Publications

  • 198
    Journal Articles
  • 3
    Book Chapter
  • 13
    Review
  • 34
    Projects
  • 25
  • 4
  • 23
  • 128

Citations / H-Index

3572 Citations
31 h-index
2647 Citations

Altmetrics

88
88
204
2118
155

Google Scholar

Co-author Network

Expertise

Biochemistry and Molecular Biology

Molecular Biology of Infectious Diseases, Recombinant Vaccine Development, Programmed Cell Death in Prokaryotes

Personal Information

Prof Rakesh Bhatnagar

Male
Amity University Jaipur Campus, SP-1, Kant Kalwar, RIICO Industrial Area, NH-11C
Jaipur, Rajasthan, India - 303002

Experience

  • Vice Chancellor

    Amity Institute of Biotechnology (Jaipur)

    Amity University, Noida

  • Vice Chancellor

    Banaras Hindu University

  • Dean

    School of Biotechnology

    Jawaharlal Nehru University

  • Vice Chancellor

    Kumaun University

Qualification

  • Ph.D

    National Sugar Institute

Honours and Awards

2016

President Award

The President of India.

2002

All India Biotech Association Award

All India Biotech Association

Fellow

Indian National Science Academy, New Delhi

Read More
2016

President Award

The President of India.

2002

All India Biotech Association Award

All India Biotech Association

Fellow

Indian National Science Academy, New Delhi

Fellow

National Academy of Sciences, Allahabad

Fellow

Indian Academy of Sciences, Bangalore

Read Less

Research Projects

Development of Nano particulate anti tubercular Drug delivery system for macrophage receptor specific targeting through oral and respiratory route: Phase I study

Funding Agency : Indian Council of Medical Research

Operation and Maintenance of P3 Facility (BSL3) for studying dangerous pathogens with special reference to anthrax causing pathogens Bacillus anthracis- [11547]ā€¯

Funding Agency : Department of Biotechnology

Role of multifunctional plasminogen biding glyceraldehyde 3 phosphate dehydrogenase of bacillus anthracis

Funding Agency : Indian Council of Medical Research

Read More

Development of Nano particulate anti tubercular Drug delivery system for macrophage receptor specific targeting through oral and respiratory route: Phase I study

Funding Agency : Indian Council of Medical Research

Operation and Maintenance of P3 Facility (BSL3) for studying dangerous pathogens with special reference to anthrax causing pathogens Bacillus anthracis- [11547]ā€¯

Funding Agency : Department of Biotechnology

Role of multifunctional plasminogen biding glyceraldehyde 3 phosphate dehydrogenase of bacillus anthracis

Funding Agency : Indian Council of Medical Research

Characterization and adjuvant potential of Poly-a- L-Glutamine of Mycobacterium tuberculosis H37Rv

Funding Agency : Department of Biotechnology

Development of novel antibiotics of control infectious disease in pathogenic bacteria through induction of programmed cell death

Funding Agency : Indian Council of Medical Research

Development of Diagnostic Kit for detection of Mycobacterium tuberculosis complex & Mycobacterial species (by whole genome sequencing).

Funding Agency : DST in collaboration with M/s. Lal Path Labs Pvt. Ltd

Identification and Characterization of immunodominant B. Cell Epitopes, that confer protective Immunity against Anthrax

Funding Agency : Department of Biotechnology

Role of Heat Shock Protein as immunodulators and their role in immunity against Bacillus anthracis infection.

Funding Agency : Council of Scientific Industrial Research

Development of transgenic BrassicaJuncea expressing normal and mutated edema factor gene for the development of vaccine against anthrax

Funding Agency : Department of Science and Technology

Rabies DNA Vaccine: Bioprocess optimization & immunogenecity studies

Funding Agency : DST in collaboration with Parental Biotech Ltd.

Cloning expression and molecular characterization of alanine racemase of Bacillus anthracis.

Funding Agency : Indian Council of Medical Research

Genome wide reconstruction and analysis of Bacillus anthracis metabolic network and its transcriptional regulation

Funding Agency : Indian Council of Medical Research (Indo-German)

Development of a bispecific single chain antibody neutralizing edema toxin and lethal toxin of anthrax

Funding Agency : DST in collaboration with Arbro Pharmaceuticals Ltd.

Creation of P3 facility for studying dangerous pathogens with special reference to anthrax causing pathogen Bacillus anthracis

Funding Agency : Department of Biotechnology

Characterization of DNA Gyrase from Bacillus anthracis: A potential target for new drugs

Funding Agency : Indian Council of Medical Research

Development of Mycobacterial Antigen Delivery System using Anthrax adenylatecyclase

Funding Agency : Department of Biotechnology

Production of recombinant vaccine against anthrax using yeast expression system

Funding Agency : Indian Council of Medical Research

Creation of Catalytically Inactive variants of edema factor and lethal factor from B. anthracis and its Application in vaccine Development against anthrax

Funding Agency : Council of scientific Industrial Research

Development of Mycobacterial Antigen Delivery System using Anthrax Toxin components

Funding Agency : Indian Council of Medical Research

Therapeutic intervention of anthrax : A molecular Medicine approach

Funding Agency : Indian Council of Medical Research

Development of DNA vaccine against rabies using targeted vectors for veterinary use (project with Dr. Anant Rai, IVRI, Izatnagar)

Funding Agency : Department of Biotechnology

Search for eco-friendly bioinsecticides from Xenorhabdusnematophila and its applications in aquaculture-a molecular approach

Funding Agency : Indian Council of Agriculture Research

Programmed cell death in pathogenic bacteria:- potential for developing novel antibiotics to control infectious diseases

Funding Agency : Department of Biotechnology

Generation of Non-toxic Lethal Factor and Edema Factor for the development of improved vaccine against Anthrax

Funding Agency : Department of Biotechnology

Search for Novel bioinsecticides from Xenorhabdusnematophilus

Funding Agency : Ministry of Environment &Forest, GOI

New strategies to control Anthraxā€“ Mapping of the lethal factor binding domain of Protective Antigen of anthrax toxin

Funding Agency : UGC under University Of Excellence Programme

Transgenic plants as a source of edible vaccine against anthrax

Funding Agency : NATP-World Bank

Production of thermostable protective antigen of Bacillus anthracis: Computational and genetic engineering approach

Funding Agency : Department of Biotechnology

Generation of non-toxic Protective antigen molecules for development of recombinant anthrax vaccine

Funding Agency : Department of Biotechnology

Cloning and Expression of non-toxic variant of protective antigen for developing recombinant vaccine against anthrax

Funding Agency : Department of Biotechnology

Major Basic proteins from Eisonophils

Funding Agency : Department of Atomic Energy

Cloning and expression of lethal factor gene of B. anthracis

Funding Agency : DRDE

Overexpression of protective antigen gene of B. anthracis

Funding Agency : DRDE

Cloning and expression of dextran sucrose gene from leuconostocmesenteroides

Funding Agency : Indian Council of Medical Research

Read Less

Publications (217)

Powered by